Jac Michael Luna

Jac Michael Luna serves as the Vice President of Molecular Design and Engineering at Kriya Therapeutics, Inc. since August 2022. Prior experience includes significant roles at BioMarin Pharmaceutical Inc. focusing on Vector Biology and Gene Therapy, and at Sangamo Therapeutics, Inc. in Gene Therapy Research and Development, where work involved the application of zinc finger DNA-binding proteins for gene regulation aimed at treating monogenic diseases. Luna has a comprehensive background in molecular biology, analytical development, and process development across various organizations including Elan Pharmaceuticals, Avigen, and Zyomyx, Inc., in addition to contributions in genomics and viral drug discovery. An academic background includes studies at Stanford University.